Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.

Oliveira Roster KI, Rönn MM, Gorenburg ER, Partl DK, Anderegg N, Abel Zur Wiesch P, Au C, Kouyos RD, Martinez FP, Low N, Grad YH

Open source

DOI: 10.1093/ofid/ofag447
Published: 2026 Jul
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag447,
  title = {Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.},
  author = {Oliveira Roster KI and Rönn MM and Gorenburg ER and Partl DK and Anderegg N and Abel Zur Wiesch P and Au C and Kouyos RD and Martinez FP and Low N and Grad YH},
  year = {2026},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofag447},
  url = {https://doi.org/10.1093/ofid/ofag447}
}

RIS

TY  - JOUR
TI  - Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.
AU  - Oliveira Roster KI
AU  - Rönn MM
AU  - Gorenburg ER
AU  - Partl DK
AU  - Anderegg N
AU  - Abel Zur Wiesch P
AU  - Au C
AU  - Kouyos RD
AU  - Martinez FP
AU  - Low N
AU  - Grad YH
PY  - 2026
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag447
UR  - https://doi.org/10.1093/ofid/ofag447
ER  -

APA

KI, O. R., MM, R., ER, G., DK, P., N, A., P, A. Z. W., C, A., RD, K., FP, M., N, L., & YH, G. (2026). Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag447

Source records

pubmed · retrieved 2026-09-25T16:31:35.219Z